H2AX and cancer: VX-970 blocks cisplatin induced P-Chk1 (S345) and elevates the levels of two DNA damage markers (P-H2AX at S139 and P-KAP1 at S824) in a concentration-dependent manner in cancer cell lines and primary human tumors.